MIRA INFORM REPORT

 

 

Report Date :

28.05.2013

 

IDENTIFICATION DETAILS

 

Name :

ORCHEV PHARMA PRIVATE LIMITED

 

 

Registered Office :

Rangoli, 1st Floor, Opposite Jaynath Petrol Pump, Gondal Road, Rajkot – 360002, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

28.06.1989

 

 

Com. Reg. No.:

04-012430

 

 

Capital Investment / Paid-up Capital :

Rs. 9.990 Millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ1989PTC012430

 

 

PAN No.:

[Permanent Account No.]

AAACO3086D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of bulk drugs.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (49)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 470000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

Financially, the company is strong but there appears a drastic dip in its net profitability.

 

However, trade relations are fair. Business is active. Payments are recorded as usually correct.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

Rangoli, 1st Floor, Opposite Jaynath Petrol Pump, Gondal Road, Rajkot – 360002, Gujarat, India

Tel. No.:

91-281-2365731/2365732

Fax No.:

91-281-236533

E-Mail :

info@archev.com

 

 

Factory:

Shapar Industrial Area, Rajkot – Gondal Highway, Veraval, District – Rajkot – 360024, Gujarat, India

Tel. No.:

91-2827-252114/252115

Fax No.:

91-2827-252113

 

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Viren Vasantbhai Patel

Designation :

Director

Address :

Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360005, Gujarat, India

Date of Appointment :

01.06.2006

DIN No.:

00544034

 

 

Name :

Mr. Chirag Vasantbhai Patel

Designation :

Director

Address :

B/9, Shree Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360005, Gujarat, India

Date of Appointment :

01.08.2006

DIN No.:

00544051

 

 

Name :

Mr. Vasantlal Odhavjibhai Bhalodia

Designation :

Director

Address :

B/9, Shree Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360005, Gujarat, India

Date of Appointment :

28.06.1989

DIN No.:

00544069

 

 

Name :

Mrs. Kanchanben Vasantlal Bhalodia

Designation :

Director

Address :

B/9, Shree Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360005, Gujarat, India

Date of Appointment :

03.10.1992

DIN No.:

00544082

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2012

 

Names of Shareholders

 

No. of Shares

Vasantlal Odhavjibhai Bhalodia

 

995

Vasantlal Odhavjibhai Bhalodia as Karta of Vasantial O Bhalodia HUF

 

1544

Kanchanben Vasantlal Bhalodia

 

707

Anilbhai Sridhar Kane

 

104

Kasturben Amrutlal Patel

 

110

Prafulkumar Vinaychandra Kamdar

 

110

Dineshkumar Harjivanbhai Patel

 

100

Ciragbhai Vasantbhai Patel

 

2568

Viren Vasantlal Patel

 

3006

Dipti Chiragbhai Patel

 

457

Bharatbhai T Kalawadia

 

78

Nitinbhai T Kalawadia

 

78

Ameeben Virenbhai Patel

 

133

 

 

 

Total

 

9990

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2012

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of bulk drugs.

 

PRODUCTION STATUS (As on 31.03.2011)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Ranitidine HCL

M.T.

1800.000

540.000

371.215

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

State Bank of India, Bhaktinagar Branch, Dhebar Raod, Rajkot – 360001, Gujarat, India

 

 

Facilities :

Secured Loan

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

Cash Credit From Banks

 

 

State Bank of India, Cash Credit A/c

A/c No.56068131677

(Secured by hypothecation of Raw Material, Finished Goods and Work in Progress, Limit

 of Rs.49.000 Millions)

6.485

10.060

SBI  Packing Credit in Foreign Currency A/c No.00000031200662659

(Secured by hypothecation of Raw Material,

  Finished Goods and Work in Progress, Limit

 of Rs.49.000 Millions)

(U.S. $ 174100 @ 50.96)

8.872

17.145

 

 

 

Total

15.357

27.205

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

H. Jamnadas and Company

Chartered Accountants

Address :

217-219, Heera Panna Complex, Dr. Yagnik Raod, Rajkot – 360001, Gujarat, India

PAN No.:

AABFH2320P

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

Rs.1000/- each

Rs.10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9990

Equity Shares

Rs.1000/- each

Rs.9.990 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

9.990

9.990

9.990

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

107.901

102.552

94.557

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

117.891

112.542

104.547

LOAN FUNDS

 

 

 

1] Secured Loans

15.357

27.205

5.417

2] Unsecured Loans

12.113

14.356

49.034

TOTAL BORROWING

27.470

41.561

54.451

DEFERRED TAX LIABILITIES

1.821

1.228

1.485

 

 

 

 

TOTAL

147.182

155.331

160.483

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

51.350

39.963

43.484

Capital work-in-progress

6.241

2.485

0.000

 

 

 

 

INVESTMENT

0.094

0.094

0.094

DEFERRED TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

54.180

67.912

78.065

 

Sundry Debtors

40.620

37.953

31.363

 

Cash & Bank Balances

4.339

2.727

3.366

 

Other Current Assets

36.459

26.915

1.245

 

Loans & Advances

0.000

0.000

24.466

Total Current Assets

135.598

135.507

138.505

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

38.208

6.872

10.798

 

Other Current Liabilities

0.914

2.584

4.363

 

Provisions

6.979

13.262

6.439

Total Current Liabilities

46.101

22.718

21.600

Net Current Assets

89.497

112.789

116.905

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

147.182

155.331

160.483

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

Income

 

 

 

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

279.697

255.139

220.396

 

 

 

Less

EXPENSES

 

 

 

 

Office Expenses

 

 

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

259.884

229.357

198.447

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

19.813

25.782

21.949

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

3.022

4.645

4.712

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

16.791

21.137

17.237

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

6.499

5.701

5.844

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

10.292

15.436

11.393

 

 

 

 

 

Less

TAX                                                                  (H)

3.202

5.118

4.066

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

7.090

10.318

7.327

 

 

 

 

 

 

PRIOR YEAR TAXATION

0.000

0.000

(0.012)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

83.052

75.606

71.171

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

1.499

1.998

1.998

 

 

Corporate Dividend Tax

0.243

0.324

0.332

 

 

General Reserve

0.550

0.550

0.550

 

BALANCE CARRIED TO THE B/S

87.850

83.052

75.606

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Sales USD $

2693677

2692553.52

27.594

 

 

Export Sales Euro

113816

819156.01

4.145

 

 

 

 

 

 

 

Earnings Per Share (Rs.)

709.71

NA

NA

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

2.53

4.04

3.32

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.59

11.39

8.22

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.09

0.14

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.23

0.14

0.52

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.94

5.96

6.27

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

OPERATION AND PROSPECTS: 

 

During the current year of operations, the Company has achieved Revenue from Operation and Other Income of Rs. 279.697 Millions as against Rs.255.139 Millions during the previous year. The production of Ranitidine for the year ended 31st March, 2012 as 304.131 M.T. The Company has earned a Profit of Rs. 198.13 Lac before depreciation and interest and a Profit of Rs. 10.292 Millions after providing for depreciation and interest. The Directors are trying their level best to improve the performance of the Company in terms of Turnover and Profitability. The prospects of the Company’s business are bright and positive.

 

UNSECURED LOAN

 

PARTICULARS

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

From Directors

10.597

11.640

From Shareholders and Directors' Relatives

1.516

2.716

Total

12.113

14.356

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24231GJ1989PTC012430

Name of the company

ORCHEV PHARMA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Rangoli, 1st Floor, Opposite Jaynath Petrol Pump, Gondal Road, Rajkot – 360002, Gujarat, India

 

Email: info@orchev.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10258643

Type of charge

Immovable Property

Book debts

Movable Property (Not Being pledge)

Floating charge

Raw Materials, Semi-Finished and Finished Goods

Particular of charge holder

(CIN: U24231GJ1989PTC012430)

State Bank of India, Bhaktinagar Branch, Dhebar Raod, Rajkot – 360001, Gujarat, India

 

Email: lokesh.yadav@sbi.co.in

Nature of instrument creating charge

Instrument Modifying Charge : Memorandum Relating to Deposit of Title Deeds for Creation of further Charge for Term Loan Overall Limit Where the Initial Charge is Created by way of Mortgage by Deposit of Title Deeds

Date of instrument Creating the charge

01.05.2013

Amount secured by the charge

Rs.66.500 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Cash Credit: 3.25% above BR (i.e. 13.95%)

EPC/FBD : As per Banks Guidelines

Credit Exposure Limit : As per Banks Guidelines

 

Terms of Repayment

Repayable on Demand subject to annual review

 

Margin

Raw Materials : Imported - -

Raw Materials : Indigenous - 25%

Semi Finished Goods - 25%

Finished Goods - 25%

Components / Consumables / Spares - 25%

Domestic Receivables - 50%

EPC - 10%

FBD - NIL

Term Loan - NIL

Letters of credit - 10%

Bank Gurantees -

 

Extent and Operation of the charge

The Charge over Properties as mentioned in Point No.15 below extends to cover the repayment of entire credit facilities of Rs.66.500 Millions viz;

 

A. Fund Based Limits

1. Cash Credit/EPC/FBD of Rs.62.500 Millions

 

B. Non-Fund Based Limits

1. Letter of Credit (Import) (Interchangeable with CC Limit) of Rs.62.500 Millions

2. Credit Exposure Limit of Rs. 4.000 Millions

 

Others

2THS

Date of instrument modifying the charge

12.04.2013

Particulars of the present modification

By virtue of this modification, the Charge over Company's Immovable property as mentioned in point no.15 above is extended to secure the repayment of enhanced credit facilities of Rs.66.500 Millions

 

 

FIXED ASSETS

 

TENGIBLE ASSETS

 

Direct Assets

 

  • Land
  • Factory Building
  • Factory Furniture
  • Factory Air Conditioner 
  • Road and Site Development
  • Plant and Machinery
  • Electrification
  • Laboratory Equipment
  • Microbiology laboratory
  • Material Handling Lift
  • Storage Tanks  Chemicals
  • Weighing Scale
  • Sulphuric Acid Tank

 

Indirect Assets

 

  • Other Building
  • Office Equipment
  • Office Attendance Machine
  • Office Air Conditioners
  • Office Furniture
  • Motor Car
  • Innova Car
  • Car  Hyundai i10
  • Car  Honda Civic
  • Two Wheelers
  • Other Misc. Assets
  • Canteen Utensils
  • Refrigerator
  • Television Set
  • Computer
  • Tractor
  • Ups and Battery
  • Mobile Phone
  • Telephone Instruments
  • Water Storage Tank
  • Water Cooler

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.61

UK Pound

1

Rs.84.18

Euro

1

Rs.71.95

 

 

INFORMATION DETAILS

 

Report Prepared by :

KVT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

49

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.